Johnson Controls has signed a joint agreement with Plylagen to develop technology that leverages the science of building microbiomes to create healthier buildings.
The agreement includes a strategic investment in Phylagen, a biotechnology company in the field of microbiome optimization of indoor environments.
According to Johnson Controls, indoor air quality improvements require an understanding of the unique indoor microbiomes of individual buildings. That includes microbial life such as viruses, bacteria and fungi that impact overall health and wellness while sharing data on the safety of indoor environments.
“Phylagen’s work provides practical and effective alignment with the Johnson Controls focus on a future committed to healthy people, healthy places and a healthy planet,” says George Oliver, chairman and CEO of Johnson Controls. “Phylagen’s ability to understand the untapped potential of the indoor microbiome is critically important as we not only respond to our new normal for managing indoor environments but prepare to make buildings safer, smarter and more responsive long term.”